Stock Track | Surgery Partners Soars 5% Intraday on Q1 Earnings Beat and Reaffirmed Guidance

Stock Track05-06

Surgery Partners' stock soared 5% during Tuesday's intraday trading session.

The surge follows the company's release of its first-quarter 2026 results, which exceeded analyst expectations. Surgery Partners reported adjusted earnings per share of -$0.03, beating the consensus estimate of -$0.12. Revenue for the quarter rose 4.5% year-over-year to $810.9 million, surpassing estimates of $797.89 million. Adjusted EBITDA of $102.3 million also came in above expectations.

Furthermore, the company reaffirmed its full-year 2026 guidance, expecting revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million. This positive earnings surprise and maintained outlook likely fueled investor confidence, driving the stock price higher.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191152361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 01:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191152361","market":"hk","top_or_hot":-1,"title":"Stock Track | Surgery Partners Soars 5% Intraday on Q1 Earnings Beat and Reaffirmed Guidance","media":"Stock Track","content":"<p>Surgery Partners' stock soared 5% during Tuesday's intraday trading session.</p><p>The surge follows the company's release of its first-quarter 2026 results, which exceeded analyst expectations. Surgery Partners reported adjusted earnings per share of -$0.03, beating the consensus estimate of -$0.12. Revenue for the quarter rose 4.5% year-over-year to $810.9 million, surpassing estimates of $797.89 million. Adjusted EBITDA of $102.3 million also came in above expectations.</p><p>Furthermore, the company reaffirmed its full-year 2026 guidance, expecting revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million. This positive earnings surprise and maintained outlook likely fueled investor confidence, driving the stock price higher.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Surgery Partners Soars 5% Intraday on Q1 Earnings Beat and Reaffirmed Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Surgery Partners Soars 5% Intraday on Q1 Earnings Beat and Reaffirmed Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-06 01:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Surgery Partners' stock soared 5% during Tuesday's intraday trading session.</p><p>The surge follows the company's release of its first-quarter 2026 results, which exceeded analyst expectations. Surgery Partners reported adjusted earnings per share of -$0.03, beating the consensus estimate of -$0.12. Revenue for the quarter rose 4.5% year-over-year to $810.9 million, surpassing estimates of $797.89 million. Adjusted EBITDA of $102.3 million also came in above expectations.</p><p>Furthermore, the company reaffirmed its full-year 2026 guidance, expecting revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million. This positive earnings surprise and maintained outlook likely fueled investor confidence, driving the stock price higher.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGRY","symbol_name":"Surgery Partners, Inc.","start_time":0,"source_url":"","article_id":"1191152361","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191152361","pubTimestamp":1778001299,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Surgery Partners' stock soared 5% during Tuesday's intraday trading session.The surge follows the company's release of its first-quarter 2026 results, which exceeded analyst expectations. Surgery...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGRY":"Surgery Partners, Inc."},"translate_title":"个股追踪|Surgery Partners因第一季度盈利超出预期并重申指引而盘中飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGRY":1},"content_text":"Surgery Partners' stock soared 5% during Tuesday's intraday trading session.The surge follows the company's release of its first-quarter 2026 results, which exceeded analyst expectations. Surgery Partners reported adjusted earnings per share of -$0.03, beating the consensus estimate of -$0.12. Revenue for the quarter rose 4.5% year-over-year to $810.9 million, surpassing estimates of $797.89 million. Adjusted EBITDA of $102.3 million also came in above expectations.Furthermore, the company reaffirmed its full-year 2026 guidance, expecting revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million. This positive earnings surprise and maintained outlook likely fueled investor confidence, driving the stock price higher.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191152361","isCrawlerRequest":true}